Tremfya (guselkumab) - J&J
Tremfya: Regulatory submissions in US/EU for Crohn's disease and ulcerative colitis between 2019-2023 (J&J) - May 16, 2019 - Pharmaceutical Business Review: Regulatory submissions in US/EU for personalized dosing psoriasis between 2019-2023 
European regulatory • sBLA
https://edge.media-server.com/m6/p/jjsewqjm
 
May 16, 2019
 
 
03c5b15b-92c5-4fec-b7ae-73bb2c4127d0.jpg